Clinical Trials on Marital Conflict

Total 1162 results

Healthpoint

Withdrawn

Using Santyl or Bacitracin on Second Degree Burns

Burn, Partial Thickness
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)

MZL

China
University of British Columbia

Recruiting

SCFE Longitudinal International Prospective Registry (SLIP)

Slipped Capital Femoral Epiphyses | SCFE

Canada
The Lymphoma Academic Research Organisation

Completed

Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas

Follicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa Associated Lymphoid Tissue

France
Ohio State University Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Terminated

Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditions

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic... and other conditions

United States
Coloplast A/S

Recruiting

Investigation of the Clinical Performance of Biatain Fiber Ag on Burns

Partial-thickness Burn

United Kingdom
Universidade Federal Fluminense

Active, not recruiting

Can Flowable Bulk Fill Composites be Used in Proximal Area of Class II Restorations (OPUSFCLASSII)

Dental Restoration Failure of Marginal Integrity

Brazil
University Health Network, Toronto

Terminated

Intra Cranial EEG Activity During Dexmedetomidine Sedation

Complex Partial Seizures

Canada
University Hospital, Ghent

Completed

Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings

Burn Wounds - Partial Thickness (2nd Degree)

Belgium
Mansoura University

Active, not recruiting

Different Treatment Modalities for Atrophied Distal Extension Maxillary Ridges

Partial Edentulism Class 1

Egypt
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

Epilepsy

Canada
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER). (LEADER)

Epilepsy

Greece
University of South Alabama

Withdrawn

Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures

Refractory Partial Seizures

United States
Dentsply Sirona Implants

Completed

Multicenter Study Comparing OsseoSpeed TX With OsseoSpeed EV.

Partial Edentulism in the Maxilla or in the Mandible

United States, Belgium, Germany, Italy
Nobelpharma

Completed

Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Partial Onset Seizures

Japan
Eisai Co., Ltd.

Completed

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

Refractory Partial Seizures

Japan
UCB Pharma

Completed

Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures

Epilepsy

France, Poland, United Kingdom, Germany, Spain, Finland, Australia, Russian Federation, Hungary, Lithuania, Sweden, Czechia, Croatia
Eisai Inc.

Completed

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Refractory Partial Seizures

Hong Kong, Italy, Australia, Spain, Portugal, Taiwan, India, Thailand, Hungary, Poland, Bulgaria, Serbia, Russian Federation, Korea, Republic of, Ukraine, Romania, Latvia, Lithuania, Germany, Estonia, Czech Republic, Philippines, Ma...
Eisai Co., Ltd.
Eisai Limited

Completed

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Epilepsy

Latvia
Novartis

Withdrawn

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

Partial Onset Seizures

United States, Austria, Spain, Estonia, Bulgaria, Latvia, Canada, India, Belgium, Lithuania, Romania
InSightec
Food and Drug Administration (FDA)

Recruiting

MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)

Epilepsy

United States
SK Life Science, Inc.

Active, not recruiting

Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS

Partial Seizure | Focal Seizure

China, Japan, Korea, Republic of
Mayo Clinic
National Institute of Neurological Disorders and Stroke (NINDS); Medtronic

Active, not recruiting

Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy

Epilepsy

United States
Integra LifeSciences Corporation

Completed

The CUSA Clarity Soft Tissue Removal Study

Benign, Malignant Tumors or Other Soft Tissue Removal | Nephrectomy or Partial Nephrectomy With Parenchyma Removal

Germany, Italy
Seoul National University Hospital
Dongsan Medical Center; Konkuk University

Completed

Efficacy and Safety of Rapid Titration Protocols of Lacosamide

Focal Epilepsy

Korea, Republic of
Eisai Inc.

Terminated

Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Refractory Partial Onset Seizures

United States
Hospices Civils de Lyon

Unknown

Cortical Excitability Assessment Using Paired Pulses (PP)

Focal Epilepsy

France
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy (ELEC3D)

Focal Epilepsy

France
Mid-Atlantic Epilepsy and Sleep Center, LLC
Eisai Inc.

Terminated

Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.

Epilepsy

United States
Lawson Health Research Institute
UCB Pharma GmbH

Terminated

Lacosamide IV and EEG/EKG (LIVE) Study (LIVE)

Focal Epilepsy

Canada
Amarantus BioScience Holdings, Inc.
Amarex Clinical Research

Unknown

Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds

Thermal Injury | Deep Partial-Thickness Burn | Full-Thickness Burn

United States
Eisai Inc.

Completed

A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

Partial Onset Seizures

France, United Kingdom, Germany, Denmark, Czech Republic, Norway, Sweden, Ireland
National Cancer Institute (NCI)

Completed

Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma

United States
Akcea Therapeutics
Ionis Pharmaceuticals, Inc.

Terminated

The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy

Familial Partial Lipodystrophy

United States, Netherlands, Belgium, Brazil, Canada, Germany, Russian Federation
Orphelia Pharma
Hospices Civils de Lyon; Institut National de la Santé Et de la Recherche Médicale... and other collaborators

Completed

Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy (SoluWest)

Infantile Spasms

France
Dong-A University Hospital

Unknown

Marginal Zone Lymphoma Cohort in Korea

Lymphoma, B-Cell, Marginal Zone

Korea, Republic of
Oregon Health and Science University
National Institute on Aging (NIA)

Completed

REmote Assessment and Dynamic Response Intervention (READyR)

Dementia | Alzheimer Disease | Relationship, Marital | Caregiver Stress Syndrome

United States
Dong-A University Hospital

Completed

Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)

Lymphoma

Korea, Republic of
Mansoura University

Recruiting

Comparative Evaluation of Class V Restorations

Secondary Caries | Dental Restoration Failure of Marginal Integrity

Egypt
Human Development Research Foundation, Pakistan
University of Liverpool; Liverpool School of Tropical Medicine; Civil Services...

Completed

Improving Psychological Well-being of Trainee Civil Servants in Pakistan

Anxiety | Psychological Distress | Well-being | Coping Skills | Psychological Capital

Pakistan
Smith & Nephew, Inc.

Completed

Post-Market Evaluation of the Rotation Medical Rotator Cuff System

Partial Thickness Supraspinatus Tendon Tear | Full Thickness Supraspinatus Tendon Tear

United States
Novartis Pharmaceuticals

Completed

Phase II BGG492 Capsule Extension for Partial Epilepsy

Partial Onset Seizures

Germany, United States, Hungary, Korea, Republic of, Poland, Slovakia
Cairo University

Unknown

Effect of the Submental Artery Island Flap Versus Maxillary Obturator Prosthesis

Patient With Partial Maxillectomy | Submental Island Flap | Maxillary Obturator

Egypt
Centre d'Investigation Clinique et Technologique...
University of Versailles

Terminated

Stimulation Galvanique Vestibulaire (GVS)

Hypertensive Hemorrhage of Right Parietal Lobe

France
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Partial Onset Seizures

Japan
SecuraBio

Withdrawn

A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)

Follicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's Lymphoma

United States
Massachusetts General Hospital
GlaxoSmithKline; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical...

Completed

Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma

Follicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma

United States
Gilead Sciences

Terminated

Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma

Follicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
French Study Group on Chronic Lymphoid Leukemia
French Innovative Leukemia Organisation; Lymphoma Study Association; Département...

Completed

Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia

Splenic Marginal Zone Lymphoma | Waldenström Macroglobulinemia | Lymphoplasmacytic Lymphoma

France

Clinical Trials on Marital Conflict

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations